Pfizer: Number of Employees 2010-2023 | PFE

Interactive chart of Pfizer (PFE) annual worldwide employee count from 2010 to 2023.
  • Pfizer total number of employees in 2023 was 88,000, a 6.02% increase from 2022.
  • Pfizer total number of employees in 2022 was 83,000, a 5.06% increase from 2021.
  • Pfizer total number of employees in 2021 was 79,000, a 0.64% increase from 2020.
  • Pfizer total number of employees in 2020 was 78,500, a 11.1% decline from 2019.
Pfizer Annual Employee Count
2023 88,000
2022 83,000
2021 79,000
2020 78,500
2019 88,300
2018 92,400
2017 90,200
2016 96,500
2015 97,900
2014 78,300
2013 77,700
2012 91,500
2011 103,700
2010 110,600
2009 116,500
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $148.698B $58.496B
Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $694.884B 115.72
Novo Nordisk (NVO) Denmark $562.108B 46.31
Johnson & Johnson (JNJ) United States $359.347B 14.26
Merck (MRK) United States $321.543B 84.63
AbbVie (ABBV) United States $297.274B 15.11
AstraZeneca (AZN) United Kingdom $217.434B 19.27
Novartis AG (NVS) Switzerland $194.425B 13.97
Sanofi (SNY) $119.271B 10.74
Innoviva (INVA) United States $0.944B 6.67